Home / Mutual Fund / Virtus Silvant Mid-Cap Growth Fund
Mutual Fund Equity Domestic Equity

Virtus Silvant Mid-Cap Growth Fund

Image specific to each asset class and market style grouping.
$ (as of )
Total Assets by Class
$228,196,211.63 (as of 03/31/2023)
Total Assets by Fund
$287,546,420.13 (as of 03/31/2023)
Morningstar Category
Mid-Cap Growth

Portfolio Overview

Investment Overview

The Fund seeks to generate capital appreciation by investing in a portfolio of U.S. mid-cap companies that exhibit strong business fundamentals and above-average growth potential. A disciplined investment process focuses on identifying positive fundamental trends, including earnings and revenue growth, improving cash flows, and increasing return on invested capital.

Effective July 25, 2022, this Fund's name and subadviser have changed.

Management Team

Investment Partner

Silvant Capital Management LLC

Silvant Capital Management is a growth equity boutique that leverages the passion and talents of a diverse, experienced group of investment professionals. Guided by their belief that growth companies can be found in every corner of the economy, Silvant strives to evaluate positive secular trends and disruptive products and services that can change the business landscape, identifying those companies best positioned to exceed investor expectations.

Learn more about Silvant Capital Management LLC

Investment Professionals

Michael Sansoterra

Michael A. Sansoterra

Chief Investment Officer, Managing Director, Senior Portfolio Manager

Industry start date: 1996
Start date as fund Portfolio Manager: 2022

Show More
Sandeep Bhatia

Sandeep Bhatia, Ph.D., CFA

Managing Director, Senior Portfolio Manager

Industry start date: 2000
Start date as fund Portfolio Manager: 2022

Show More
Sowmdeb Sen

Sowmdeb Sen

Managing Director, Portfolio Manager

Industry start date: 1999
Start date as fund Portfolio Manager: 2022

Show More

Key Features

Growth as a Condition, Not a Category

Searches for mid-cap growth opportunities across the market, including segments overlooked by many traditional growth managers

Extensive Fundamental Research

Bottom-up analysis strives to identify well-run businesses with positive investment characteristics and potential to grow earnings faster than peers

Focused on True Game Changers

Evaluates secular trends and disruptive products and services with potential to disrupt the business landscape and exceed investor expectations

Portfolio Characteristics


(as of 12/30/2022)
Average Weighted Market Cap (billions) $28.60
Median Market Cap (billions) $23.34
Trailing P/E Ex-Negative Earnings 22.87
Price-to-Cash Flow 26.20
Price-to-Book Value 6.71
3-Year Earnings Growth Rate 17.01

Top Holdings (% Fund)

(as of 12/30/2022)
AmerisourceBergen Corp
Quanta Services Inc
Keysight Technologies Inc
Dexcom Inc
Westinghouse Air Brake Technologies Corp
Enphase Energy Inc
Hexcel Corp
O'Reilly Automotive Inc
Palo Alto Networks Inc
Waste Management Inc

Holdings are subject to change.

Sector Allocation (% Equity)

(as of 12/30/2022)
Information Technology
Health Care
Consumer Discretionary
Real Estate
Communication Services

Performance & Risk

Growth of $10,000 Investment

From to
This chart assumes an initial investment of $10,000 made on for Class ddd shares including any applicable sales charges. Performance assumes reinvestment of dividends and capital gain distributions.


As of
As of

Performance data quoted represents past results. Past performance is no guarantee of future results and current performance may be higher or lower than the performance shown. Investment return and principal value will fluctuate, so your shares, when redeemed, may be worth more or less than their original cost.

Sales Charge and Expenses

Risk Statistics3

(as of )
Fund Index
Std Dev

Risk Considerations

Market Volatility: The value of the securities in the portfolio may go up or down in response to the prospects of individual companies and/or general economic conditions. Local, regional, or global events such as war, terrorism, pandemic, or recession could impact the portfolio, including hampering the ability of the portfolio's manager(s) to invest its assets as intended.
Issuer Risk: The portfolio will be affected by factors specific to the issuers of securities and other instruments in which the portfolio invests, including actual or perceived changes in the financial condition or business prospects of such issuers.
Equity Securities: The market price of equity securities may be adversely affected by financial market, industry, or issuer-specific events. Focus on a particular style or on small, medium, or large-sized companies may enhance that risk.
Prospectus: For additional information on risks, please see the fund's prospectus.



Market Review

Growth equities rose broadly in the quarter, capping off a volatile year. Gains were driven by cooler inflation numbers and investor optimism that the surge in Consumer Price Index (CPI) increases that have weighed on markets and driven interest rates higher may have peaked. The Federal Reserve (Fed) also slowed the pace of its federal funds rate hikes from four straight 0.75% increases to 0.5% in December, not exactly dovish behavior but a notable downshift nonetheless.

Cyclical stocks led the rally, with value securities generally outperforming growth names as revenue and earnings expectations reset lower on anticipated slowing economic growth. The Russell Midcap® Growth Index gained 6.90% in the period to end 2022 down 26.72%, with the largest sector increases for the quarter in utilities (+16.56%), energy (+14.98%), healthcare (+14.53%), and real estate (+13.52%). Communication services (-11.72%) was the only sector to post a decline.


The Virtus Silvant Mid-Cap Growth Fund gained 4.83% (Class INST) for the quarter versus the Russell Midcap Growth Index’s rise of 6.90%. The largest performance detractors included information technology, communication services, and financials stock selection. The largest return contributors included industrials, consumer discretionary, and healthcare stock selection.

Dexcom and AmerisourceBergen were among the top stock contributors.

  • Medical device firm Dexcom rose on higher-than-expected earnings and revenue. The company, which offers continuous glucose monitoring systems for diabetes management, benefited from strong new patient volume gains. It also received FDA approval for its next-generation device, Dexcom G7, which should help continue to accelerate its market expansion and lead to upside volume growth in 2023. We trimmed the position but continued to hold the stock given its favorable performance and upbeat outlook.
  • Pharmaceutical distributor AmerisourceBergen outperformed on revenue strength and increased forward-looking guidance. We maintained the position as we see room for additional gains. An overhang for the stock was also lifted near the end of the quarter when Walgreens Boots Alliance, which owns a stake in the company, announced it had reduced its position from approximately 20% to approximately 17%. Investors had anticipated that a sale may be coming but were uncertain on the amount.
  • Additional contributors included Westinghouse Air Brake Technologies, O’Reilly Automotive, and Tractor Supply Co.  

Zscaler and Trade Desk were among the largest stock detractors.

  • Despite strong earnings results, cloud security company Zscaler lagged on decelerating billings growth and an elongating sales cycle requiring more C-level approvals. We continued to hold the stock but are closely monitoring it given these concerns. We also generally have been trimming some of the Fund’s software exposure.
  • Digital marketing firm Trade Desk, a top contributor last quarter, underperformed on a broad slowdown in the ad segment, which pressured revenue and year-over-year growth. We trimmed the position but continued to hold the stock because the company has continued to gain market share and remains well positioned for when the ad market stabilizes.
  • Additional top detractors included ZoomInfo Technologies, Palo Alto Networks, and Chart Industries.

Portfolio Changes

New holdings included Inspire Medical Systems and LPL Financial Holdings. Exits included Generac Holdings and ZoomInfo Technologies.

  • We purchased medical technology firm Inspire Medical Systems, which develops minimally invasive solutions for obstructive sleep apnea, on its strong revenues and accelerating growth.
  • We bought independent broker-dealer LPL Financial Holdings based on its net new advisory assets gains, growing bank channel market share, and increased net interest income due to rising interest rates.
  • We sold battery storage and power generator company Generac Holdings on slowing backlog growth and increased competition.
  • We exited cloud-based marketing solutions firm ZoomInfo Technologies given decelerating billings growth and concerns about managements’ quick reversal from raising guidance to lowering it just two weeks later.


Looking ahead, we believe the general market positives remain moderately ahead of the potential negatives. Employment continues to be healthy, which is good news for consumer sentiment and income, particularly real wages as inflation begins to come down. The Fed’s tightening cycle is likely near its peak, and China’s reopening from zero-COVID lockdowns should be supportive of increased global demand. If consumers keep spending, job growth remains resilient, and inflation continues to moderate, the broader economy may be able to avoid recession. That seems more probable now than it did last quarter, and if it proves to be the case, stocks should be able to gain, though the path may be volatile. 

Still, market expectations have clearly reset for a slower growth rate. The question at this point is whether revenue and earnings outlooks have come down enough? In this environment, we continue to focus on bottom-up company fundamentals, seeking out businesses whose key metrics are inflecting, where growth is a condition, rather than a category. In our view, these are the stocks that should continue to offer the potential to surprise markets on the upside and reward investors.

The commentary is the opinion of the subadviser. This material has been prepared using sources of information generally believed to be reliable; however, its accuracy is not guaranteed. Opinions represented are subject to change and should not be considered investment advice or an offer of securities.

Related Literature

Marketing Materials

Virtus Silvant Mid-Cap Growth Fund Fact Sheet - A
Virtus Silvant Mid-Cap Growth Fund Fact Sheet - INST
Statement on Regional Banks

Financial Materials

Virtus Investment Trust Statutory Prospectus
Virtus Silvant Mid-Cap Growth Fund Summary Prospectus
Virtus Investment Trust SAI
Virtus Investment Trust Annual Report
Virtus Investment Trust Semiannual Report


Virtus Silvant Mid-Cap Growth Fund Monthly Holdings
Virtus Silvant Mid-Cap Growth Fund Top Holdings
Virtus Silvant Mid-Cap Growth Fund Holdings Fiscal Q1
Virtus AllianzGI Mid-Cap Growth Fund Holdings Fiscal Q3

Investors should carefully consider the investment objectives, risks, charges and expenses of any Virtus Mutual Fund before investing. The prospectus and summary prospectus contains this and other information about the fund. Please contact your financial representative, call 1-800-243-4361 to obtain a current prospectus and/or summary prospectus. You should read the prospectus and/or summary prospectus carefully before you invest or send money.

Performance data quoted represents past results. Past performance is no guarantee of future results and current performance may be higher or lower than the performance shown. Investment return and principal value will fluctuate, so your shares, when redeemed, may be worth more or less than their original cost.

Average annual total return is the annual compound return for the indicated period. It reflects the change in share price and the reinvestment of all dividends and capital gains. NAV returns do not include the effect of any applicable sales charges. POP and w/CDSC returns include the effect of maximum applicable sales charges.

Returns for periods of less than one year are cumulative total returns.

1 Yields/Distributions: 30-day SEC Yield is a standardized yield calculated according to a formula set by the SEC, and is subject to change. 30-day SEC Yield (unsubsidized) is the 30-day SEC Yield without the effect of applicable expense waivers. Distribution Rate is calculated by (a) annualizing the latest income distribution for fixed income funds or funds less than 1 year old, or (b) summing all income distributions over the preceding 12 months for all other funds, and dividing by the NAV on the last business date of the period, unless otherwise indicated. The Distribution Rate may be comprised of ordinary income, net realized capital gains and returns of capital.

2 Distribution History: Distributions are represented on a cash basis and may be reclassified at year end for tax purposes. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. STCG: Short Term Capital Gain, LTCG: Long Term Capital Gain

3 Risk Statistics: R2 is a statistical measure that represents the percentage of a fund or security's movements that can be explained by movements in a benchmark index. Beta is a quantitative measure of the volatility of a given portfolio to the overall market. Alpha is a risk adjusted measure of an investment's excess return relative to a benchmark. A positive Alpha indicates that the investment produced a return greater than expected for the risk (as measured by Beta) taken. Standard Deviation measures variability of returns around the average return for an investment fund. Higher standard deviation suggests greater risk. Risk Statistics are calculated using 36 monthly returns.

4 Characteristics: For Equity Funds: Avg. Weighted Market Cap (bn): The sum of each security's weight within the fund (or index) multiplied by the security's market capitalization. Trailing P/E Ex-Negative Earnings: Per-share stock price divided by the latest 12-months Earnings per Share; Price/Cash Flow: Per-share stock price divided by the per-share operating cash flow; Price/Book: Per-share stock price divided by the latest 12-month per-share Book Value; 3-Year EPS Growth Rate: Average of earnings per share growth for latest 3-year period. The 3-Year EPS Growth Rate is not a forecast of the fund's performance.

4 Characteristics: For Fixed Income Funds: Effective Duration represents the interest rate sensitivity of a fixed income fund. For example, if a fund's effective duration is five years, a 1% increase in interest rates would result in a 5% decline in the fund's price. Similarly, a 1% decline in interest rates would result in a 5% gain in the fund's price.

Morningstar Disclosures:
The Morningstar Rating for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. Ratings do not take into account the effects of sales charges and loads.

© Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.